Literature DB >> 20682340

Early changes in the hypothalamic region in prodromal Huntington disease revealed by MRI analysis.

Charlotte Soneson1, Magnus Fontes, Yongxia Zhou, Vladimir Denisov, Jane S Paulsen, Deniz Kirik, Asa Petersén.   

Abstract

Huntington disease (HD) is a fatal neurodegenerative disorder caused by an expanded CAG repeat. Its length can be used to estimate the time of clinical diagnosis, which is defined by overt motor symptoms. Non-motor symptoms begin before motor onset, and involve changes in hypothalamus-regulated functions such as sleep, emotion and metabolism. Therefore we hypothesized that hypothalamic changes occur already prior to the clinical diagnosis. We performed voxel-based morphometry and logistic regression analyses of cross-sectional MR images from 220 HD gene carriers and 75 controls in the Predict-HD study. We show that changes in the hypothalamic region are detectable before clinical diagnosis and that its grey matter contents alone are sufficient to distinguish HD gene carriers from control cases. In conclusion, our study shows, for the first time, that alterations in grey matter contents in the hypothalamic region occur at least a decade before clinical diagnosis in HD using MRI.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20682340      PMCID: PMC2955781          DOI: 10.1016/j.nbd.2010.07.013

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  50 in total

Review 1.  Voxel-based morphometry--the methods.

Authors:  J Ashburner; K J Friston
Journal:  Neuroimage       Date:  2000-06       Impact factor: 6.556

2.  The distribution of structural neuropathology in pre-clinical Huntington's disease.

Authors:  M J Thieben; A J Duggins; C D Good; L Gomes; N Mahant; F Richards; E McCusker; R S J Frackowiak
Journal:  Brain       Date:  2002-08       Impact factor: 13.501

3.  A voxel-based method for the statistical analysis of gray and white matter density applied to schizophrenia.

Authors:  I C Wright; P K McGuire; J B Poline; J M Travere; R M Murray; C D Frith; R S Frackowiak; K J Friston
Journal:  Neuroimage       Date:  1995-12       Impact factor: 6.556

4.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

Authors: 
Journal:  Cell       Date:  1993-03-26       Impact factor: 41.582

5.  Orexin loss in Huntington's disease.

Authors:  Asa Petersén; Joana Gil; Marion L C Maat-Schieman; Maria Björkqvist; Heikki Tanila; Inês M Araújo; Ruben Smith; Natalija Popovic; Nils Wierup; Per Norlén; Jia-Yi Li; Raymund A C Roos; Frank Sundler; Hindrik Mulder; Patrik Brundin
Journal:  Hum Mol Genet       Date:  2004-11-03       Impact factor: 6.150

Review 6.  Functional imaging in Huntington's disease.

Authors:  Jane S Paulsen
Journal:  Exp Neurol       Date:  2009-01-03       Impact factor: 5.330

7.  Onset and rate of striatal atrophy in preclinical Huntington disease.

Authors:  E H Aylward; B F Sparks; K M Field; V Yallapragada; B D Shpritz; A Rosenblatt; J Brandt; L M Gourley; K Liang; H Zhou; R L Margolis; C A Ross
Journal:  Neurology       Date:  2004-07-13       Impact factor: 9.910

8.  Topography of cerebral atrophy in early Huntington's disease: a voxel based morphometric MRI study.

Authors:  J Kassubek; F D Juengling; T Kioschies; K Henkel; J Karitzky; B Kramer; D Ecker; J Andrich; C Saft; P Kraus; A J Aschoff; A C Ludolph; G B Landwehrmeyer
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-02       Impact factor: 10.154

9.  A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length.

Authors:  D R Langbehn; R R Brinkman; D Falush; J S Paulsen; M R Hayden
Journal:  Clin Genet       Date:  2004-04       Impact factor: 4.438

10.  Neuroendocrine disturbances in Huntington's disease.

Authors:  Nadine Saleh; Stéphane Moutereau; Alexandra Durr; Pierre Krystkowiak; Jean-Philippe Azulay; Christine Tranchant; Emmanuel Broussolle; Françoise Morin; Anne-Catherine Bachoud-Lévi; Patrick Maison
Journal:  PLoS One       Date:  2009-03-25       Impact factor: 3.240

View more
  30 in total

1.  Dysfunctions in circadian behavior and physiology in mouse models of Huntington's disease.

Authors:  Takashi Kudo; Analyne Schroeder; Dawn H Loh; Dika Kuljis; Maria C Jordan; Kenneth P Roos; Christopher S Colwell
Journal:  Exp Neurol       Date:  2010-12-22       Impact factor: 5.330

2.  Mitochondrial division inhibitor 1 protects against mutant huntingtin-induced abnormal mitochondrial dynamics and neuronal damage in Huntington's disease.

Authors:  Maria Manczak; P Hemachandra Reddy
Journal:  Hum Mol Genet       Date:  2015-10-12       Impact factor: 6.150

Review 3.  Mutant huntingtin, abnormal mitochondrial dynamics, defective axonal transport of mitochondria, and selective synaptic degeneration in Huntington's disease.

Authors:  P Hemachandra Reddy; Ulziibat P Shirendeb
Journal:  Biochim Biophys Acta       Date:  2011-11-04

Review 4.  Genetics and neuropathology of Huntington's disease.

Authors:  Anton Reiner; Ioannis Dragatsis; Paula Dietrich
Journal:  Int Rev Neurobiol       Date:  2011       Impact factor: 3.230

5.  Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's disease.

Authors:  Ulziibat P Shirendeb; Marcus J Calkins; Maria Manczak; Vishwanath Anekonda; Brett Dufour; Jodi L McBride; Peizhong Mao; P Hemachandra Reddy
Journal:  Hum Mol Genet       Date:  2011-10-13       Impact factor: 6.150

6.  Stable Atlas-based Mapped Prior (STAMP) machine-learning segmentation for multicenter large-scale MRI data.

Authors:  Eun Young Kim; Vincent A Magnotta; Dawei Liu; Hans J Johnson
Journal:  Magn Reson Imaging       Date:  2014-05-09       Impact factor: 2.546

7.  Social Cognition and Oxytocin in Huntington's Disease: New Insights.

Authors:  Elisa Unti; Sonia Mazzucchi; Daniela Frosini; Cristina Pagni; Gloria Tognoni; Lionella Palego; Laura Betti; Fabiana Miraglia; Gino Giannaccini; Roberto Ceravolo
Journal:  Brain Sci       Date:  2018-08-26

8.  Differential effects of early environmental enrichment on emotionality related behaviours in Huntington's disease transgenic mice.

Authors:  Thibault Renoir; Terence Y C Pang; Christina Mo; Grace Chan; Caroline Chevarin; Laurence Lanfumey; Anthony J Hannan
Journal:  J Physiol       Date:  2012-10-08       Impact factor: 5.182

9.  Sleep and circadian dysfunction in neurodegenerative disorders: insights from a mouse model of Huntington's disease.

Authors:  Dika Kuljis; Analyne M Schroeder; Takashi Kudo; Dawn H Loh; David L Willison; Christopher S Colwell
Journal:  Minerva Pneumol       Date:  2012-09

10.  Early-onset sleep defects in Drosophila models of Huntington's disease reflect alterations of PKA/CREB signaling.

Authors:  Erin D Gonzales; Anne K Tanenhaus; Jiabin Zhang; Ryan P Chaffee; Jerry C P Yin
Journal:  Hum Mol Genet       Date:  2015-11-24       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.